Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Valeria Santini, MD, University of Florence, Florence, Italy, discusses the incidence of thrombocytopenia in low-risk myelodysplastic syndromes (MDS), outlining strategies for management. This interview took place at the 16th International Congress on Myelodysplastic Syndromes, held virtually in 2021.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.